| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |